Oramed Pharmaceuticals (ORMP) Q1 2025 Earnings — Miss Estimates

Screener

Reported May 15, 2025 · Before market open

Revenue$2.0M

EPS-$0.19Miss by $0.16

EPS estimate-$0.03

Next report

Nov 12, 2026 (in 2 months)

EPS estimate$0.43

Versus estimates

Revenue

Q1 2025$2.0M

Diluted EPS

Q2 2026-$0.09Miss by $0.52 Q1 2026-$0.16 Q4 2025-$0.06Beat by $0.02 Q3 2025$1.13Beat by $1.17 Q2 2025-$0.05Miss by $0.01

Q1 2025-$0.19Miss by $0.16

FAQ

When did Oramed Pharmaceuticals report Q1 2025 earnings?: Oramed Pharmaceuticals (ORMP) reported Q1 2025 earnings on May 15, 2025 before market open.
What were Oramed Pharmaceuticals's Q1 2025 revenue and EPS?: Oramed Pharmaceuticals reported revenue of $2.0M and eps of $-0.19 for Q1 2025.
Did Oramed Pharmaceuticals beat estimates in Q1 2025?: EPS missed the consensus estimate of $-0.03 by $0.16.
Where can I find Oramed Pharmaceuticals's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001213900-25-044193) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Oramed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk